this stock is undervalued, page-22

Hi hoofa,

"Assuming 260 work days available, that is 17% of his time per year is spent on OBJ. What about the company for the other 215 days. Must just manage itself."

For a company managing itself, it sure knows how to attract some good partners...

aabebi posted, this stock is undervalued - Once the big news pours in, it will be too late to get on board. This stock is due for big times ahead."

hoofa, you replied with, "aabebi - sounds very much like a post I placed some 3.5 years ago -:)"

MG also replied with, "aabebi, Quick, better tell management. Don't want to see them miss out."

I can understand MG's bitterness towards OBJ as he announced his decision back on 18/06/13 to sell out when OBJ was only trading @ 1c allowing him to invest in an ASX listed which is commonly renown for making false and misleading statements to hoodwink investors. I even took the liberty of responding to MG highlighting a couple of red flags on the UNS threads back on 21/08/13 with the knowledge that a large majority of traders, like MG (by his own admission) prefer not to conduct any research. Unfortunately for traders/investors there are very strict laws in Australia which are designed to prevent researchers from being able to share valuable information on a public forum relating to any fraudulent activity, and as a result Australians are not afforded the same level of freedom of speech or protection as our US counterparts. So, despite threats received from Australia, people like the Deputy Chief of Reporters of Forbes magazine who managers the Fact-Checking and Research efforts at Forbes still have the freedom to protect US investors from companies listed on the ASX as they see fit, and as was the case in an article on UNS published even more recently on 09/09/13 by Forbes. Some very serious allegations from people in the know that if found to be true would have to put the true value of the $164m MktCap company well into negative territory.

hoofa, back to your comment, "aabebi - sounds very much like a post I placed some 3.5 years ago -:)" - (Your first post on the OBJ threads was 2.8 years ago, but close enough ;)

I have often said that hotcopper, when used wisely can be a valuable (and reliable) source of information - far more so than anything you'll ever see through the ASX.

It doesn't take much to find that, aabebi has only posted a total of 19 times on only 4 Biotech stocks since becoming a member of this site in 2007 - and ALL of which have rallied soon after...

PRR in 2008 @ $0.006c with a post simply titled, dendreon - and I can unequivocally confirm that no 'trader' in this country would've had any understanding of what this meant at the time, however the stock went on to rally + 6,483% higher.
NEU in 2009 @ $0.033c with a post comparing a similar company in the US working with neurological disorders - It gained + 54.54% within just over a month after posting, before doing an OBJ sideways thing in recent years with the fundamentals (also) getting stronger - currently however it's now moved + 309.09% since the first contribution.
BLT in 2012 posting, This is great news and with news like this, this stock should be beyond .03 today." - BLT is 'beyond' 50c today. (with consolidation + 45.71%

OBJ in 2009 (four years ago) aabebi posted his (I'm assuming aabebi is a 'he') first and only post on the OBJ forum (until his very recent reappearance). It was titled;

if only this deal was with obj
"I was thinking that it would be fantastic to see headlines like 3M in deal with OBJ Limited re eM patches. This was the latest news from 3M's website: 3M Drug Delivery Systems announced that it has signed a deal with VaxInnate Corporation under which VaxInnate acquires the use of 3M's patented toll-like receptor or TLR agonists for use as vaccine adjuvants."

Although aabebi didn't receive any response to his first post on the OBJ threads back in 2009 I'm assuming that he knows a thing or two about the science because next generation TDDS and adjuvants are the key to creating vaccines with higher efficacy and safety rates because they provide longer shelf life and enhanced delivery performance - both of which OBJ's ETP technology has already been scientifically proven to do (alone) beyond anything which is currently available in the market.

So, while we all know a contract was executed between OBJ and 3M to evaluate OBJ's eM-patch (ETP) technology, judging by aabebi's 100% success rate for picking good Biotech stocks just before they're about to run, my instinct tells me that he probably also knew who was behind VaxInnate Corporation before making that first post on the OBJ forum back in 2009:



Gotta run, but I'll add more to this post as soon as I get the chance...